Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bird, C. R.
Right arrow Articles by Hodak, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bird, C. R.
Right arrow Articles by Hodak, J. A.

Radiology, Vol 169, 123-126, Copyright © 1988 by Radiological Society of North America

ARTICLES

Gd-DTPA-enhanced MR imaging in pediatric patients after brain tumor resection

CR Bird, BP Drayer, M Medina, HL Rekate, RA Flom and JA Hodak
Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, AZ 85013.

A prospective study was conducted in 15 pediatric patients who had undergone resection of intracranial tumors. The object of the study was to determine the safety and efficacy of magnetic resonance (MR) imaging performed after the administration of gadolinium diethylenetriamine- pentaacetic acid (Gd-DTPA) in evaluating residual or recurrent tumor. Precontrast T1-weighted, intermediate, and T2-weighted images were obtained at a field strength of 1.5 T. Gd-DTPA was then injected intravenously in a dose of 0.1 mmol per kilogram of body weight. T1- weighted images were obtained within 5 minutes after the injection, intermediate and T2-weighted images were obtained 10 minutes after the injection, and T1-weighted images were obtained approximately 20 minutes after the injection. None of the patients experienced allergic reactions or other side effects. Physical examination findings and laboratory values were unchanged after the Gd-DTPA-enhanced examination. In six patients, contrast-enhanced images depicted tumor not suspected on nonenhanced images. In four other patients, enhanced images provided better definition of the tumor core. The images of one patient with a brain stem tumor showed no evidence of enhancement. Pre- and postcontrast images of three previously treated patients showed no evidence of tumor. Gd-DTPA appears to be a safe and effective contrast agent for MR imaging and provides a more accurate method of imaging in the follow-up of brain tumors in pediatric patients.


This article has been cited by other articles:


Home page
 Am. J. Neuroradiol.Home page
A. C. M. Maia Jr, S. M. F. Malheiros, A. J. da Rocha, C. J. da Silva, A. A. Gabbai, F. A. P. Ferraz, and J. N. Stavale
MR Cerebral Blood Volume Maps Correlated with Vascular Endothelial Growth Factor Expression and Tumor Grade in Nonenhancing Gliomas
AJNR Am. J. Neuroradiol., April 1, 2005; 26(4): 777 - 783.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Neuroradiol.Home page
S. Cha, E. A. Knopp, G. Johnson, A. Litt, J. Glass, M. L. Gruber, S. Lu, and D. Zagzag
Dynamic Contrast-enhanced T2*-weighted MR Imaging of Recurrent Malignant Gliomas Treated with Thalidomide and Carboplatin
AJNR Am. J. Neuroradiol., May 1, 2000; 21(5): 881 - 890.
[Abstract] [Full Text]

Home page
 CLIN PEDIATRHome page
D. A. Gusnard and R. A. Zimmerman
Computed Tomography Versus Magnetic Resonance Imaging -: Of the Pediatric Central Nervous System Techniques, Indications, and Examples
Clinical Pediatrics, March 1, 1990; 29(3): 136 - 157.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
RADIOLOGY RADIOGRAPHICS RSNA JOURNALS ONLINE
Copyright © 1988 by the Radiological Society of North America.